BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34744096)

  • 21. Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure.
    Yang Y; Reincke M; Williams TA
    Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):100-108. PubMed ID: 30130807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism.
    Hannon MJ; Sze WC; Carpenter R; Parvanta L; Matson M; Sahdev A; Druce MR; Berney DM; Waterhouse M; Akker SA; Drake WM
    QJM; 2017 May; 110(5):277-281. PubMed ID: 28180906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Re-evaluation of the diagnostic value and optimal cutoff point of captopril challenge test in diagnosis of primary aldosteronism].
    Luo Y; He WW; Cheng QF; Yang SM; Du ZP; Mei M; Xu ZX; Hu JB; Wang KR; He YF; Li QF; Song Y
    Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):60-65. PubMed ID: 34979771
    [No Abstract]   [Full Text] [Related]  

  • 24. Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism.
    Yang Y; Williams TA; Song Y; Yang S; He W; Wang K; Cheng Q; Ma L; Luo T; Yang J; Reincke M; Burrello J; Li Q; Mulatero P; Hu J
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32898224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Adrenal Venous Sampling With Outcomes in Primary Aldosteronism for Unilateral Adenomas.
    Thiesmeyer JW; Ullmann TM; Stamatiou AT; Limberg J; Stefanova D; Beninato T; Finnerty BM; Vignaud T; Leclerc J; Fahey TJ; Brunaud L; Mirallie E; Zarnegar R
    JAMA Surg; 2021 Feb; 156(2):165-171. PubMed ID: 33146695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Machine learning-based models for predicting clinical outcomes after surgery in unilateral primary aldosteronism.
    Kaneko H; Umakoshi H; Ogata M; Wada N; Ichijo T; Sakamoto S; Watanabe T; Ishihara Y; Tagami T; Iwahashi N; Fukumoto T; Terada E; Katsuhara S; Yokomoto-Umakoshi M; Matsuda Y; Sakamoto R; Ogawa Y
    Sci Rep; 2022 Apr; 12(1):5781. PubMed ID: 35388079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of surgical treatment of primary aldosteronism.
    Citton M; Viel G; Rossi GP; Mantero F; Nitti D; Iacobone M
    Langenbecks Arch Surg; 2015 Apr; 400(3):325-31. PubMed ID: 25567077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism.
    Kim JH; Ahn CH; Kim SJ; Lee KE; Kim JW; Yoon HK; Lee YM; Sung TY; Kim SW; Shin CS; Koh JM; Lee SH
    Endocrinol Metab (Seoul); 2022 Apr; 37(2):369-382. PubMed ID: 35417953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patients.
    Vorselaars WMCM; van Beek DJ; Postma EL; Spiering W; Borel Rinkes IHM; Valk GD; Vriens MR;
    Surgery; 2019 Jul; 166(1):61-68. PubMed ID: 31053245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
    Umakoshi H; Sakamoto R; Matsuda Y; Yokomoto-Umakoshi M; Nagata H; Fukumoto T; Ogata M; Ogawa Y
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31665338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome success after operative treatment for primary aldosteronism.
    Picado O; Whitfield BW; Khan ZF; Jeraq M; Farrá JC; Lew JI
    Surgery; 2021 Mar; 169(3):528-532. PubMed ID: 32948336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism.
    Yuan Y; Li N; Liu Y; Wang M; Heizhati M; Zhu Q; Yao X; Luo Q
    Endocrine; 2022 Mar; 75(3):889-898. PubMed ID: 34780033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of adrenalectomy in patients with primary hyperaldosteronism--a single centre experience.
    Hartmann I; Grepl M; Vidlar A; Smakal O; Vaclavik J; Frysak Z; Dolezel M; Student V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):583-90. PubMed ID: 25471827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using plasma aldosterone concentrations at 1 h of saline infusion test for the diagnosis of primary aldosteronism.
    Phonanuwong R; Jannoo S; Chanthanuwat S; Soonthornpun S
    J Hypertens; 2023 Sep; 41(9):1493-1497. PubMed ID: 37432888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robot-assisted Partial Adrenalectomy for the Treatment of Conn's Syndrome: Surgical Technique, and Perioperative and Functional Outcomes.
    Simone G; Anceschi U; Tuderti G; Misuraca L; Celia A; De Concilio B; Costantini M; Stigliano A; Minisola F; Ferriero M; Guaglianone S; Gallucci M
    Eur Urol; 2019 May; 75(5):811-816. PubMed ID: 30077398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.
    Kim IY; Park IS; Kim MJ; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Kwak IS; Song SH; Chung HC
    Int Urol Nephrol; 2018 Oct; 50(10):1887-1895. PubMed ID: 29779118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
    Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
    J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictors of long-term outcomes after targeted therapy for primary Aldosteronism.
    Chen YY; Huang SC; Pan CT; Peng KY; Lin LY; Chan CK; Shun CT
    J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S135-S140. PubMed ID: 38097431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of aldosterone/direct renin ratio before drug washout in the screening of primary aldosteronism].
    Ma WJ; Lou Y; Bian J; Cai J; Zhang HM; Zhou XL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(41):3250-3254. PubMed ID: 33167113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.